1. Home
  2. OLMA vs ILLR Comparison

OLMA vs ILLR Comparison

Compare OLMA & ILLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • ILLR
  • Stock Information
  • Founded
  • OLMA 2006
  • ILLR 2015
  • Country
  • OLMA United States
  • ILLR United States
  • Employees
  • OLMA N/A
  • ILLR N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • ILLR Investment Managers
  • Sector
  • OLMA Health Care
  • ILLR Finance
  • Exchange
  • OLMA Nasdaq
  • ILLR Nasdaq
  • Market Cap
  • OLMA 289.0M
  • ILLR 304.1M
  • IPO Year
  • OLMA 2020
  • ILLR N/A
  • Fundamental
  • Price
  • OLMA $4.11
  • ILLR $0.61
  • Analyst Decision
  • OLMA Strong Buy
  • ILLR
  • Analyst Count
  • OLMA 4
  • ILLR 0
  • Target Price
  • OLMA $26.75
  • ILLR N/A
  • AVG Volume (30 Days)
  • OLMA 939.3K
  • ILLR 436.9K
  • Earning Date
  • OLMA 03-18-2025
  • ILLR 05-15-2025
  • Dividend Yield
  • OLMA N/A
  • ILLR N/A
  • EPS Growth
  • OLMA N/A
  • ILLR N/A
  • EPS
  • OLMA N/A
  • ILLR N/A
  • Revenue
  • OLMA N/A
  • ILLR $45,244,000.00
  • Revenue This Year
  • OLMA N/A
  • ILLR N/A
  • Revenue Next Year
  • OLMA N/A
  • ILLR N/A
  • P/E Ratio
  • OLMA N/A
  • ILLR N/A
  • Revenue Growth
  • OLMA N/A
  • ILLR N/A
  • 52 Week Low
  • OLMA $3.93
  • ILLR $0.53
  • 52 Week High
  • OLMA $16.62
  • ILLR $8.86
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 37.74
  • ILLR N/A
  • Support Level
  • OLMA $3.93
  • ILLR N/A
  • Resistance Level
  • OLMA $4.45
  • ILLR N/A
  • Average True Range (ATR)
  • OLMA 0.31
  • ILLR 0.00
  • MACD
  • OLMA 0.04
  • ILLR 0.00
  • Stochastic Oscillator
  • OLMA 21.95
  • ILLR 0.00

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About ILLR Triller Group Inc. Common Stock

Triller Group Inc is a us-based company that operates its businesses through Triller Corp which operates as a technology platform and AGBA Group Holding Limited operates as an insurance and wealth distribution platform.

Share on Social Networks: